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9q and 20, where, respectively, chromosomal loss and gain is frequently detected in SCA III ovarian tumors (7, 8) . After selecting the genes on these respective chromosomes, hierarchical clustering is performed. Sorting the genes on chromosomal order reveals particular chromosomal regions with under-or overexpressed genes in subsets of SCA III tumors. Possible retention or amplification on chromosome 9p in all tumors and predominant chromosomal loss on chromosome 9q in a number of SCA III tumors is observed. When analyzed in the same way, chromosome 20 reveals potential amplified regions in the majority of tumors ( Figure 1 , B and C).
Application of this method gives direct insight into the chromosomal distribution of up-or down-regulated genes. It reveals continuous regions with gene expression biases. The visualization of these biases is a first step in better understanding of the relations between physical loss or gain of chromosomal regions and the effects of gene expression of genes located in these regions. This observation may also affect the significance of microarray expression data. Up-regulating of a gene within a region of other upregulated genes may be due to genomic instability and can be less significant than a solitary up-regulated gene. The macro and the user manual are available from the authors at http://cms-dev. We describe a method to produce an Escherichia coli transcription activator and assay its function in vitro in a coupled transcription and eukaryotic translation (CTT) reaction. The model transcription activator used here is CRP (also called CAP), a well-known E. coli catabolic regulator protein. In the presence of cyclic-AMP (cAMP), the CRP-cAMP complex binds to a CRPdependent promoter, interacts with RNA polymerase and stimulates transcription at the promoter (1-4).
In the experiments described here, we use T3 RNA polymerase to produce CRP in vitro from a plasmid, pT3CRP, which has the CRP gene, crp, transcribed from a T3 promoter (Figure 1 ).
The function of CRP is tested with a reporter plasmid, p42crp-luc, which has a synthetic CRP-dependent promoter and the firefly luciferase gene, luc. The synthetic promoter has the following features: (i) it has a -10 site of E. coli consensus promoter to ensure a high promoter activity upon activation; (ii) BENCHMARKS it lacks a functional -35 site so that the basal activity is low; and (iii) it has a CRP-binding site centered at -41.5 position. This ensemble constitutes a class II CRP-dependent E. coli promoter (5,6). The expression of luc from the promoter can be monitored in a CTT reaction with a luminometer (7).
The CTT reaction uses a coupled transcription and translation kit (TNT ® T3 Coupled Wheat Germ Extract System; Promega, Madison, WI, USA), which uses wheat germ extract for translation. The components in the kit, excluding RNA polymerase, are first mixed according to the instructions. Luciferin (Promega) is added to the mixture to 0.4 mM (from a 20 mM stock solution in 10 mM Tris-Cl, pH 8.0, stored at -70°C). For sampleto-sample uniformity, this CTT mixture is prepared batch-wise, divided in aliquots, and stored at -70°C. The transcription activity assay reaction is made of 10 μL CTT mixture plus 0.5 U σ 70 -saturated E. coli RNA polymerase (Epicentre, Madison, WI, USA), 0.03 nM reporter plasmid DNA, and other ingredients (specified below). The final concentration is about 10% lower than that recommended for CTT by the kit. At this slightly lowered concentration, the reaction is less sensitive to volume variation. To improve precision, reactions of four activation conditions are carried out in parallel. The common ingredients, such as reporter plasmid DNA and RNA polymerase, are first mixed in a larger volume. The larger volume is then di- 
vided to the four individual reactions to which other ingredients specific to each reaction are added.
At the time of experiment, the reactions are prepared in clear 0.2-mL PCR tubes at 0°C. The temperature of the tubes is raised to room temperature (22°-23°C) to start CTT. Although the CTT reaction temperature can be raised to at least 30°C, we choose room temperature for convenience. Each reaction is monitored with a photomultiplier tube (PMT) of a four-channel luminometer. The relative luminescence unit (RLU) is recorded with a computer. The transcription level of luc can be estimated from RLU values. The variation of RLU is around 10% among repeated reactions.
Functional CRP can be produced and assayed either in two separate CTT reactions (referred to as premade CRP) or in a combined reaction (referred to as in situ activation). Premade CRP is produced in 10 μL CTT reaction with 2% (v/v) T3 RNA polymerase (Promega; included in the CTT kit) and 0.15 nM pT3CRP DNA. The reaction lasts for 100 min at room temperature, and it is terminated by adding 5 μL glycerol and stored at -20°C as premade CRP preparation. In the following experiment, we use 3% (v/v) premade CRP preparation and 2 μM cAMP (Sigma, St. Louis, MO, USA) in an assay reaction (Figure 2A) . For in situ activation, we add T3RNA polymerase (2%, v/v) and pT3CRP DNA (0.075 nM) directly to another assay reaction. As a reference, we include a positive control reaction with pConsensus-luc. This plasmid has a constitutively active consensus promoter in place of the CRP-dependent promoter on p42crp-luc ( Figure  1 ). Also included is a negative control reaction with premade CRP but without cAMP. Figure 2A shows promoter activity of reactions as reported by luc expression. In the presence of cAMP and CRP, the CRP-dependent promoter activity is as active as the consensus promoter. CRP can be supplied to the promoter either in situ or premade. In the case of in situ activation, there is an additional lag of luc expression, which reflects the time needed to produce enough CRP. In contrast to the active state, in the absence of cAMP (negative control) CRPdependent promoter gives very low luc expression. Therefore, the transcription at the CRP-dependent promoter is clearly cAMP dependent, confirming the identity of CRP as the activator protein. The low level of luc expression in negative control also shows that wheat germ extract has no detectable amount of either endogenous cAMP or cAMPindependent activator.
Next, we tested in situ activation dependence on pT3CRP DNA concentration ( Figure 2B ). The luc expression is approximately proportional to the concentration of pT3CRP. Evidently CRPdependent promoter activity is proportional to CRP concentration, which in turn, is proportional to pT3CRP concentration. The very low luc expression without p3TCRP indicates that wheat germ extract has no detectable amount of endogenous CRP-like activator. Finally, we observe CRP activation at various concentrations of cAMP (Figure 2C) . The activity at 2 μM cAMP is near maximum (higher than 2 μM cAMP not shown), and the half-activation concentration of cAMP is between 0.6 and 0.8 μM. The cAMP dose response is comparable to what has been previously reported (8, 9) .
In the experiments, we apply CTT to produce CRP from its DNA coding sequences and to observe CRP transcription activation in near real-time. We use wheat germ extract to avoid the interference from endogenous CRP and cAMP, which are usually present in E. coli 30-S extract. Combining activator production and assay in one, the reaction mimics a simple in vivo gene expression circuit.
